QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TFX

QT66Teleflex Incorporated
NYSE·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
127.00
+2.04+1.63%
OverviewShort InterestFilings
TFXQT66Teleflex Incorporated·NYSE
OverviewShort InterestFilings
127.00+1.63%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-22.80
Insider Own0.89%
Shs Outstand44.27M
Perf Week-1.79%
Market Cap5.53BForward P/E12.04EPS next Y10.55Insider Trans0.00%Shs Float-Perf Month-4.32%
Enterprise Value7.91BPEG-EPS next Q1.28Inst Own-Short Float-Perf Quarter18.64%
Income-1009037565.00P/S1.97EPS this Y129.40%Inst Trans-Short Ratio-Perf Half Y1.71%
Sales2.81BP/B1.79EPS next Y57.31%ROA-14.87%Short Interest-Perf YTD4.06%
Book/sh69.66P/C17.60EPS next 5Y18.68%ROE-28.27%52W High139.67 -9.07%Perf Year8.06%
Cash/sh6.98P/FCF22.22EPS past 3/5Y-ROIC2.73%52W Low100.18 26.77%Perf 3Y-
Dividend Est.1.36 (1.07%)EV/EBITDA-89.39Sales past 3/5Y-10.62% -4.71%Gross Margin53.27%Volatility2.13% 1.90%Perf 5Y-
Dividend TTM1.36 (1.07%)EV/Sales2.81EPS Y/Y TTM624.32%Oper. Margin6.48%ATR (14)4.03Perf 10Y-
Dividend Ex-DateMay 22, 2026Quick Ratio2.03Sales Y/Y TTM-7.75%Profit Margin-35.89%RSI (14)46.22Recom2.20
Dividend Gr. 3/5Y0.00% 0.00%Current Ratio2.55EPS Q/Q-52.23%SMA20-2.22%Beta0.89Target Price144.67
Payout-5.96%Debt/Eq0.87Sales Q/Q-21.83%SMA50-1.80%Rel Volume0.69Prev Close124.96
Employees14,100LT Debt/Eq0.84EarningsJul 30SMA2005.62%Avg Volume802.90KPrice127.00
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.14.88% 2.05%Net Debt/EBITDA-26.86Volume557,448Change1.63%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-08-26UpgradePiper SandlerNeutral → Overweight$245 → $160
May-08-26ReiteratedRaymond JamesOutperform$128 → $150
May-08-26ReiteratedMizuho Securities$135 → $140
May-08-26UpgradeRBC CapitalSector Perform → Outperform$135 → $155
Mar-27-26UpgradeRaymond JamesMarket Perform → Outperform$355 → $128
Feb-26-26ReiteratedNeedhamBuy$138 → $147
Jan-29-26ReiteratedWells FargoEqual Weight$139 → $116
Jan-27-26UpgradeNeedhamHold → Buy$355 → $138
Dec-18-25ReiteratedTruist Financial$120 → $135
Dec-17-25ReiteratedRBC CapitalSector Perform$120 → $135
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,8111,9933,047
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,3148721,345
Gross Profit1,4971,1211,703
Selling, General and Administrative Excl. Other945720995
Research and Development189145162
Other Operating Expense1810395
Operating Income181256151
Interest Expense11410084
Unusual Expense
———
Non-Operating Income (Expense)438131-8
Net Income Before Taxes-3202575
Income Taxes-25-345
Consolidated Net Income-1,008-90670
Net Income From Continuing Operations-2955970
Net Income-1,008-90670
EPS (Recurring)-22.80-20.301.49
EPS (Basic, Before Extraordinaries)-22.80-20.301.49
EPS (Diluted)-22.80-20.251.48
EBITDA-88303434
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.992.76—
Gross Margin53.2656.2555.89
Operating Margin6.4412.844.96
Net Margin-35.86-45.462.30
Shares Outstanding444547
Market Capitalization5,5885,492—
Operating Lease Expense
———
Insider Trading Volume
$135.43$121.17$106.91$92.65$78.39● Close Price0.00K158.40K316.80K475.19K633.59KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
HAGGERTY GRETCHEN RDirectorAug 06 '25Buy114.7550057,3756,305Aug 07 12:00 AM
Ryu JaewonDirectorAug 05 '25Buy115.001,500172,5003,727Aug 07 12:00 AM
Kelly LiamChairman, President & CEOAug 05 '25Buy115.071,500172,60545,267Aug 07 12:00 AM
RANDLE STUART ADirectorAug 05 '25Buy115.861,000115,8607,547Aug 07 12:00 AM
Krakauer Andrew ADirectorAug 05 '25Buy115.251,000115,2507,192Aug 07 12:00 AM
Duncan Candace HDirectorMay 05 '25Option Exercise123.049,6661,189,3049,561May 07 12:00 AM
Logue Daniel V.CVP, General Counsel & SectyFeb 20 '25Option Exercise121.003,240392,04014,328Feb 21 12:00 AM
Klasko Stephen K. M.D.DirectorFeb 20 '25Option Exercise121.005,348647,1089,827Feb 21 12:00 AM
Kelly LiamChairman, President & CEOFeb 19 '25Option Exercise121.4172,9288,854,39863,556Feb 21 12:00 AM
RANDLE STUART ADirectorAug 16 '24Option Exercise121.005,348647,1088,170Aug 16 12:00 AM
RANDLE STUART ADirectorAug 16 '24Sale238.932,674638,8995,496Aug 16 12:00 AM
Hicks Cameron PCorp. VP & Chief HR OfficerMar 05 '24Option Exercise135.1414,8022,000,39417,451Mar 05 12:00 AM
Hicks Cameron PCorp. VP & Chief HR OfficerMar 05 '24Sale225.007,4011,665,22510,050Mar 05 12:00 AM
Logue Daniel V.CVP, General Counsel & SectyFeb 26 '24Option Exercise101.123,050308,41612,278Feb 28 12:00 AM
Kelly LiamChairman, President & CEODec 27 '23Option Exercise101.8752,5125,349,14244,726Dec 29 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR